GHRP-6 x5, Ipamorelin x5

GHRP-6 x5 and Ipamorelin x5 typically refer to a bundle of five vials each of two popular growth hormone–releasing peptides used in research and performance-focused contexts. GHRP-6 is known for its strong stimulation of growth hormone release through activation of the ghrelin receptor, often accompanied by a noticeable increase in appetite. This makes it appealing in scenarios where enhanced caloric intake and mass gain are desired.

In contrast, Ipamorelin is considered a more selective growth hormone secretagogue. It stimulates GH release with minimal impact on cortisol and prolactin levels and generally does not cause the intense hunger associated with GHRP-6. Because of this, Ipamorelin is often favored for lean muscle development, recovery, and anti-aging research without significant metabolic side effects.

When combined in a “x5” package, users typically aim to leverage the complementary effects of both peptides—GHRP-6 for its potent GH pulse and appetite stimulation, and Ipamorelin for its smoother, more controlled GH release. This combination may support muscle growth, fat metabolism, improved sleep, and recovery.

However, these peptides are still largely classified for research purposes, and long-term safety data remains limited. Potential side effects include water retention, increased hunger, and mild hormonal fluctuations, so careful and informed use is essential.